A Randomized, Placebo-Controlled, Multiple Ascending Dose Study To Assess The Safety, Pharmacokinetics and Pharmacodynamics Of CS-8080 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs CS 8080 (Primary)
- Indications Arterial occlusive disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Daiichi Sankyo Inc
- 10 Jun 2017 Biomarkers information updated
- 19 Dec 2008 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 19 Dec 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.